SAMSN1 and hepatocellular carcinoma: found that SAMSN1 was downregulated in hepatocellular carcinoma (HCC) and related to the malignant phenotype of HCC; multivariate analysis confirmed SAMSN1 as an independent prognostic factor of HCC progression (12).